Table 2.
Assessment of tumor response (30 patients).
| Response | N (%) | 95% CI |
|---|---|---|
| Complete response, n (%) | 9 (30) | 13.6–46.4 |
| Partial response, n (%) | 14 (46.7) | 28.8–64.5 |
| Stable disease, n (%) | 1 (3.3) | 0.1–17.2 |
| Progressive disease, n (%) | 6 (20) | 7.7–38.6 |
| ORR, n (%) | 23 (76.7) | 57.7–90.1 |
| DCR, n (%) | 24 (80) | 61.4–92.3 |
| Observed duration of response ≥6 months, n (%) | 18 (60) | |
| PFS, median (range) | 16 (1–23) | |
| OS, median (range) | 18 (1–23) | |
| Median observed time to response, months (range) | 2 (1–5) |
ORR, overall response rate (defined as complete response + partial response); DCR, disease control rate (defined as complete response + partial response + stable disease); PFS, progression-free survival; OS, overall survival.